Problems of Administering Drugs by Continuous Infusion
Related Articles
- Pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous... Berg, Stacey L.; Cowan, Kenneth H. // JNCI: Journal of the National Cancer Institute;1/19/94, Vol. 86 Issue 2, p143
Studies the pharmacokinetics of taxol and doxorubicin administered alone and in combination by continuous 72-hour infusion. Dosage and administration cycles; Determination of plasma levels of the drugs; Clearance rates of the drugs.
- New delivery. // Drug Topics;4/6/98, Vol. 142 Issue 7, p75
Reports that Boehringer Mannheim's dieuretic, Demadex can be administered as a continuous infusion. How the product was administered.
- Continuous infusion versus bolus injection of furosemide in pediatric patients after cardiac surgery: a meta-analysis of randomized studies. ZANGRILLO, ALBERTO; CABRINI, LUCA; BIONDI-ZOCCAI, GIUSEPPE G. L.; MONTI, GIACOMO; TURI, STEFANO; SHEIBAN, IMAD; BIGNAMI, ELENA; LANDONI, GIOVANNI // Signa Vitae;4/1/2012, Vol. 7 Issue 1, p17
Introduction. Acute renal failure and fluid retention are common problems in pediatric patients after cardiac surgery. Furosemide, a loop diuretic drug, is frequently administered to increase urinary output. The aim of the present study was to compare efficacy and complications of continuous...
- Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results. Stocchi, F.; Vacca, L.; De Pandis, M. F.; Barbato, L.; Valente, M.; Ruggieri, S. // Neurological Sciences;Feb2001, Vol. 22 Issue 1, p93
Fluctuations in motor disability and dyskinesias are the major problem in the long-term treatment of Parkinson's disease (PD). Many authors and ourselves have shown that by giving patients a continuous infusion of levodopa it is possible to control motor fluctuations. Levodopa can be...
- Infusion Phlebitis: Relative Incidence Associated with Cefuroxime Administered by Intermittent and Continuous Infusion. Owens, C.A.; Ambrose, P.G.; Quintiliani, R.; Nightingale, C.H.; Nicolau, D.P. // Clinical Drug Investigation;1998, Vol. 15 Issue 6, p531
Examines the relative incidence of infusion phlebitis associated with cefuroxime administered by intermittent and continuous infusion. Placement site; Catheter failure rate; Overall incidence of phlebitis.
- Cost analysis of continuous versus intermittent infusion of piperacillin--tazobactam: A time--motion study. Florea, Naomi R.; Kotapati, Srividya; Kuti, Joseph L.; Geissler, Erika C.; Nightingale, Charles H.; Nicolau, David P. // American Journal of Health-System Pharmacy;11/15/2003, Vol. 60 Issue 22, p2321
Compares the time and associated costs of administering a continuous versus an intermittent intravenous infusion of piperacillin-tazobactam. Total labor cost for each regimen; Dosing formulations; Drug acquisition costs; Average wholesale price and hospital contract price of...
- Getting paid for services still No.1 problem for infusion industry. Levy, Sandra // Drug Topics;4/2/2001, Vol. 145 Issue 7, p46
Deals with the problems of the home drug infusion industry in the United States. Suggestions to improve the payment systems for home drug infusion providers; Factors that affect the home drug infusion industry.
- Problems with Y-tube connectors. Uppal, Rajvinder; Moors, Tony // British Journal of Midwifery;Apr2007, Vol. 15 Issue 4, p237
A letter to the editor is presented which informs the potential problem that may occur while administering infusions of syntocinon using Y connector.
- Herceptin. // Royal Society of Medicine: Medicines;2002, p281
This article presents information on the drug Herceptin, a proprietary preparation of the anticancer drug trastuzumab. It can be used in the treatment of a particular type of breast cancer, and is administered by intravenous infusion.
- Continuous Infusion or Bolus Injection in Cancer Chemotherapy. Carlson, Robert W.; Sikic, Branimir Ivan // Annals of Internal Medicine;Dec83, Vol. 99 Issue 6, p823
Discusses the status of long-term venous access, ambulatory continuous-infusion-pump technology, rationale for continuous intravenous infusion of certain anticancer drugs and the major clinical trials using such infusions. Available means of venous access; Types of ambulatory...
